Nonalcoholic Steatohepatitis Completed Phase 1 Trials for Pegbelfermin (DB15365)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03445208A Study of Experimental Medication BMS-986036 Given to Healthy ParticipantsTreatment
NCT03674476An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney FunctionTreatment